Last updated on June 2019

A Sourcing Study to Collect Human Blood Samples From Healthy Adults


Brief description of study

The purpose of this study is to collect large volumes of matched pairs of pre- and post-vaccination sera from healthy subjects who will be administered GlaxoSmithKline (GSK) Biologicals' vaccine against meningitis- MenACWY vaccine (Menveo) or rMenB+OMV NZ vaccine (Bexsero), which will serve for the development, qualification, validation and maintenance of immunological assays and will support the preclinical research activities and clinical development of GSK Biologicals' vaccines. The safety of the subjects given one of the 2 vaccines (Bexsero or Menveo), as per the recommended dosage and schedule will be assessed during their participation in the study.

Clinical Study Identifier: NCT03493919

Find a site near you

Start Over